Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
Argus Health
McKesson
Farmers Insurance
Express Scripts
Chubb
Daiichi Sankyo
Moodys
Mallinckrodt

Generated: August 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin susp isophane recombinant human

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo Nordisk Inc
NOVOLIN N
insulin susp isophane recombinant human
INJECTABLE;INJECTION019959NDANovo Nordisk0169-1834-021 VIAL in 1 CARTON (0169-1834-02) > 10 mL in 1 VIAL
Novo Nordisk Inc
NOVOLIN N
insulin susp isophane recombinant human
INJECTABLE;INJECTION019959NDANovo Nordisk0169-1834-111 VIAL in 1 CARTON (0169-1834-11) > 10 mL in 1 VIAL
Novo Nordisk Inc
NOVOLIN N
insulin susp isophane recombinant human
INJECTABLE;INJECTION019959NDATYA Pharmaceuticals64725-1834-110 mL in 1 VIAL (64725-1834-1)
Lilly
HUMULIN N
insulin susp isophane recombinant human
INJECTABLE;INJECTION018781NDAEli Lilly and Company0002-8315-011 VIAL in 1 CARTON (0002-8315-01) > 10 mL in 1 VIAL
Lilly
HUMULIN N
insulin susp isophane recombinant human
INJECTABLE;INJECTION018781NDAEli Lilly and Company0002-8315-171 VIAL in 1 CARTON (0002-8315-17) > 3 mL in 1 VIAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Citi
McKinsey
Fish and Richardson
Healthtrust
Johnson and Johnson
Chinese Patent Office
Express Scripts
Colorcon
Novartis

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot